To assess the activation of NF-κB in response to drugs that are clinically used to treat colon cancer, NF-κB reporter cells were established by lentivirus-mediated transduction of a construct made of NF-κB response elements fused to the luciferase gene. The gene discussed is NFKB1; the disease is malignant colon neoplasm.